In a significant move aimed at tackling high prescription drug costs, President Donald Trump has launched TrumpRx.gov, a federal government-backed website that provides Americans with access to dramatically reduced prices on dozens of commonly prescribed medications. The initiative, which builds on the administration's Most-Favored-Nation pricing approach, promises savings

In a seismic shift for American healthcare, President Donald Trump's revived Most Favored Nations (MFN) policy is slashing prescription drug prices by tying them to the lowest rates in other developed countries, promising billions in savings for patients and taxpayers. But as the administration secures landmark deals with major pharmaceutical giants, critics point to a history of Democratic resistance.